자산수익률비율 (ROA)
2005년부터
계산
Johnson & Johnson, ROA, 장기 추세계산
| ROA | = | 100 | × | 순이익1 | ÷ | 총 자산1 | |
|---|---|---|---|---|---|---|---|
| 2023. 12. 31. | 20.98% | = | 100 | × | 35,153) | ÷ | 167,558) |
| 2022. 12. 31. | 9.57% | = | 100 | × | 17,941) | ÷ | 187,378) |
| 2021. 12. 31. | 11.47% | = | 100 | × | 20,878) | ÷ | 182,018) |
| 2020. 12. 31. | 8.41% | = | 100 | × | 14,714) | ÷ | 174,894) |
| 2019. 12. 29. | 9.59% | = | 100 | × | 15,119) | ÷ | 157,728) |
| 2018. 12. 30. | 10.00% | = | 100 | × | 15,297) | ÷ | 152,954) |
| 2017. 12. 31. | 0.83% | = | 100 | × | 1,300) | ÷ | 157,303) |
| 2016. 12. 31. | 11.71% | = | 100 | × | 16,540) | ÷ | 141,208) |
| 2015. 12. 31. | 11.55% | = | 100 | × | 15,409) | ÷ | 133,411) |
| 2014. 12. 28. | 12.45% | = | 100 | × | 16,323) | ÷ | 131,119) |
| 2013. 12. 29. | 10.42% | = | 100 | × | 13,831) | ÷ | 132,683) |
| 2012. 12. 30. | 8.94% | = | 100 | × | 10,853) | ÷ | 121,347) |
| 2011. 12. 31. | 8.51% | = | 100 | × | 9,672) | ÷ | 113,644) |
| 2010. 12. 31. | 12.96% | = | 100 | × | 13,334) | ÷ | 102,908) |
| 2009. 12. 31. | 12.95% | = | 100 | × | 12,266) | ÷ | 94,682) |
| 2008. 12. 28. | 15.25% | = | 100 | × | 12,949) | ÷ | 84,912) |
| 2007. 12. 30. | 13.06% | = | 100 | × | 10,576) | ÷ | 80,954) |
| 2006. 12. 31. | 15.67% | = | 100 | × | 11,053) | ÷ | 70,556) |
| 2005. 12. 31. | 17.94% | = | 100 | × | 10,411) | ÷ | 58,025) |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-29), 10-K (보고 날짜: 2018-12-30), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-28), 10-K (보고 날짜: 2013-12-29), 10-K (보고 날짜: 2012-12-30), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-28), 10-K (보고 날짜: 2007-12-30), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
Johnson & Johnson, ROA, 장기 추세, 경쟁사와의 비교
| Johnson & Johnson | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023. 12. 31. | 20.98% | 3.61% | 6.91% | 8.43% | 5.64% | 8.19% | 9.12% | 0.34% | -25.58% | 0.94% | 11.95% | 6.07% |
| 2022. 12. 31. | 9.57% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 13.30% | 32.34% | 15.91% | 14.85% | 7.15% |
| 2021. 12. 31. | 11.47% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 12.35% | 49.46% | 12.11% | 31.75% | 8.12% |
| 2020. 12. 31. | 8.41% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 7.72% | -10.18% | 6.23% | 20.47% | 9.23% |
| 2019. 12. 29. | 9.59% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 11.66% | -32.34% | 9.72% | 14.29% | 6.33% |
| 2018. 12. 30. | 10.00% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 7.53% | -19.61% | 7.00% | 20.83% | 5.22% |
| 2017. 12. 31. | 0.83% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 2.72% | — | 12.40% | 13.67% | 3.93% |
| 2016. 12. 31. | 11.71% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 4.11% | — | 4.20% | 12.84% | 4.40% |
| 2015. 12. 31. | 11.55% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 4.36% | — | 4.16% | 11.34% | 4.83% |
| 2014. 12. 28. | 12.45% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.12% | — | 5.40% | 8.99% | 4.42% |
| 2013. 12. 29. | 10.42% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 4.17% | — | 12.78% | 14.38% | 4.00% |
| 2012. 12. 30. | 8.94% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 5.81% | — | 7.84% | 36.06% | 4.29% |
| 2011. 12. 31. | 8.51% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 5.97% | — | 5.32% | -16.75% | 4.96% |
| 2010. 12. 31. | 12.96% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 0.81% | — | 4.23% | -9.59% | 4.85% |
| 2009. 12. 31. | 12.95% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 11.51% | — | 4.05% | -9.15% | 3.93% |
| 2008. 12. 28. | 15.25% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 16.54% | — | 7.29% | -12.34% | 4.71% |
| 2007. 12. 30. | 13.06% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 6.77% | — | 7.07% | -11.28% | 3.59% |
| 2006. 12. 31. | 15.67% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 9.95% | — | 16.84% | -17.49% | 0.79% |
| 2005. 12. 31. | 17.94% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 10.33% | — | 6.88% | -22.54% | 5.25% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-29), 10-K (보고 날짜: 2018-12-30), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-28), 10-K (보고 날짜: 2013-12-29), 10-K (보고 날짜: 2012-12-30), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-28), 10-K (보고 날짜: 2007-12-30), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Johnson & Johnson, ROA, 장기 추세, 산업 부문과 비교: 제약, 생명공학 및 생명과학
| Johnson & Johnson | 제약, 생명공학 및 생명과학 | |
|---|---|---|
| 2023. 12. 31. | 20.98% | 6.57% |
| 2022. 12. 31. | 9.57% | 11.04% |
| 2021. 12. 31. | 11.47% | 11.19% |
| 2020. 12. 31. | 8.41% | 5.14% |
| 2019. 12. 29. | 9.59% | 8.90% |
| 2018. 12. 30. | 10.00% | 8.71% |
| 2017. 12. 31. | 0.83% | 5.27% |
| 2016. 12. 31. | 11.71% | 8.66% |
| 2015. 12. 31. | 11.55% | 9.03% |
| 2014. 12. 28. | 12.45% | 9.59% |
| 2013. 12. 29. | 10.42% | 9.55% |
| 2012. 12. 30. | 8.94% | 8.35% |
| 2011. 12. 31. | 8.51% | 7.32% |
| 2010. 12. 31. | 12.96% | 7.23% |
| 2009. 12. 31. | 12.95% | 10.17% |
| 2008. 12. 28. | 15.25% | 10.52% |
| 2007. 12. 30. | 13.06% | 8.98% |
| 2006. 12. 31. | 15.67% | 12.00% |
| 2005. 12. 31. | 17.94% | 10.50% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-29), 10-K (보고 날짜: 2018-12-30), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-28), 10-K (보고 날짜: 2013-12-29), 10-K (보고 날짜: 2012-12-30), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-28), 10-K (보고 날짜: 2007-12-30), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Johnson & Johnson, ROA, 장기 추세, 업계와의 비교: 의료
| Johnson & Johnson | 의료 | |
|---|---|---|
| 2023. 12. 31. | 20.98% | 6.08% |
| 2022. 12. 31. | 9.57% | 8.60% |
| 2021. 12. 31. | 11.47% | 8.69% |
| 2020. 12. 31. | 8.41% | 5.36% |
| 2019. 12. 29. | 9.59% | 7.15% |
| 2018. 12. 30. | 10.00% | 6.08% |
| 2017. 12. 31. | 0.83% | 5.31% |
| 2016. 12. 31. | 11.71% | 6.93% |
| 2015. 12. 31. | 11.55% | 7.37% |
| 2014. 12. 28. | 12.45% | 8.18% |
| 2013. 12. 29. | 10.42% | 8.29% |
| 2012. 12. 30. | 8.94% | 7.68% |
| 2011. 12. 31. | 8.51% | 7.00% |
| 2010. 12. 31. | 12.96% | 6.99% |
| 2009. 12. 31. | 12.95% | 9.19% |
| 2008. 12. 28. | 15.25% | 8.56% |
| 2007. 12. 30. | 13.06% | 8.18% |
| 2006. 12. 31. | 15.67% | 9.77% |
| 2005. 12. 31. | 17.94% | 9.09% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-29), 10-K (보고 날짜: 2018-12-30), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-28), 10-K (보고 날짜: 2013-12-29), 10-K (보고 날짜: 2012-12-30), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-28), 10-K (보고 날짜: 2007-12-30), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).